CHAAN S NG to Proto-Oncogene Proteins c-ret
This is a "connection" page, showing publications CHAAN S NG has written about Proto-Oncogene Proteins c-ret.
Connection Strength
0.096
-
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. J Clin Oncol. 2011 Jul 01; 29(19):2660-6.
Score: 0.078
-
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clin Cancer Res. 2009 Nov 15; 15(22):7061-8.
Score: 0.018